| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CFO | EVP, CFO &Cbo | Senior Vice President, CFO
2 companies
Mahatme Sandesh is an EVP, CFO &Cbo at Sarepta Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 9 sells.
Estimated insider holdings value: $333K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2019 | SRPT Sarepta Therapeutics, Inc. | EVP, CFO &Cbo | Sale+OE | 125,000 | $125.50 | $15,687,500.00 | -80.6% | |
| Feb 7, 2019 | SRPT Sarepta Therapeutics, Inc. | EVP, CFO &Cbo | Sale+OE | 65,000 | $145.00 | $9,425,000.00 | -88.3% | |
| Jan 31, 2019 | SRPT Sarepta Therapeutics, Inc. | EVP, CFO &Cbo | Sale+OE | 65,000 | $130.23 | $8,465,262.56 | -79.0% | |
| Oct 24, 2018 | SRPT Sarepta Therapeutics, Inc. | EVP, CFO &Cbo | Sale+OE | 107,524 | $127.74 | $13,735,115.76 | -83.9% | |
| Jul 20, 2017 | SRPT Sarepta Therapeutics, Inc. | EVP, CFO &Cbo | Sale+OE | 50,000 | $41.00 | $2,050,000.00 | -34.0% | |
| Oct 17, 2016 | SRPT Sarepta Therapeutics, Inc. | Senior Vice President, CFO | Sale+OE | 30,000 | $50.08 | $1,502,502.00 | -48.8% |